Latest News:  
Beijing   Sunny    13 / 1   City Forecast

Home>>Life & Culture

U.S. FDA approves first cord blood product

(Xinhua)

09:58, November 14, 2011

WASHINGTON, Nov. 11 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved HEMACORD, the first licensed hematopoietic progenitor cells-cord cell therapy.

HEMACORD is indicated for use in hematopoietic stem cell transplantation procedures in patients with disorders affecting the blood forming system. For example, cord blood transplants have been used to treat patients with certain blood cancers and some inherited metabolic and immune system disorders.

"The use of cord blood hematopoietic progenitor cell therapy offers potentially life-saving treatment options for patients with these types of disorders," said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement.

HEMACORD contains hematopoietic progenitor cells (HPCs) from human cord blood. Cord blood is one of three sources of HPCs used in transplants. The other two are bone marrow and peripheral blood. Once these HPCs are infused into patients, the cells migrate to the bone marrow where they divide and mature. When the mature cells move into the bloodstream they can partially or fully restore the number and function of many blood cells, including immune function.

 
 
     
 
 
 
     
 
 
 
  We Recommend  
 
 
 
     
 
 

Email|Print|Comments(Editor:实习生1)

Leave your comment0 comments

  1. Name

  

Selections for you


  1. Chinese president attends APEC meeting in Hawaii

  2. Probe into charity's real estate spending

  3. "World New Seven Wonders of Nature" unveiled

  4. Gold copies of animal head sculptures of Yuanmingyuan

Most Popular

Opinions

  1. AirSea Battle plan renews old hostility
  2. China in APEC: a mutually beneficial endeavor
  3. World hopes APEC can kick-start economy
  4. Vision will drive changes to ruling system
  5. Hopes for future of country must be realistic
  6. 'RMB undervaluation' claims defy economic logic
  7. US unlikely to contain China's rise
  8. India's border troop surge aimed at rising China?
  9. Anxious US looks toward Asia
  10. Property curbs to remain despite price drop

What's happening in China

Shanghai launches website on guide dogs

  1. Taobao Mall accused of cheating
  2. China's first institute for tea study to open
  3. Greater gov't role sought to prevent diabetes
  4. Li Ning sees departure of another executive
  5. Expo site to become cultural center

PD Online Data

  1. The dragon dance
  2. Temple fairs in Beijing
  3. Lunar New Year´s Eve (I)
  4. Lunar New Year´s Eve (II)
  5. Little New Year (I)